Literature DB >> 14624201

The efficacy of high-dose olanzapine versus clozapine in treatment-resistant schizophrenia: a double-blind crossover study.

Robert R Conley, Deanna L Kelly, Charles M Richardson, Carol A Tamminga, William T Carpenter.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 14624201     DOI： 10.1097/01.jcp.0000096246.29231.73

Source DB:  PubMed          Journal:  J Clin Psychopharmacol        ISSN： 0271-0749            Impact factor:   3.153


× No keyword cloud information.
  17 in total

1.  Augmentation of olanzapine in treatment-resistant schizophrenia.

Authors:  Mathias Zink
Journal:  J Psychiatry Neurosci       Date:  2005-11       Impact factor: 6.186

2.  High-dose olanzapine for bipolar depression: proceed with caution.

Authors:  Vidya Perera; Alan Forrest; Junzhe Xu
Journal:  Prim Care Companion CNS Disord       Date:  2014-10-23

3.  Combination and high-dose atypical antipsychotic therapy in patients with schizophrenia: systematic review.

Authors: 
Journal:  CADTH Technol Overv       Date:  2012-09-01

Review 4.  Augmentation strategies in clozapine-resistant schizophrenia.

Authors:  Gary Remington; Amitabha Saha; Siow-Ann Chong; Chekkera Shammi
Journal:  CNS Drugs       Date:  2005       Impact factor: 5.749

5.  Strong Treatment Response and High Maintenance Rates of Clozapine in Childhood-Onset Schizophrenia.

Authors:  Lauren I Kasoff; Kwangmi Ahn; Peter Gochman; Diane D Broadnax; Judith L Rapoport
Journal:  J Child Adolesc Psychopharmacol       Date:  2016-01-19       Impact factor: 2.576

Review 6.  Clozapine versus other atypical antipsychotics for schizophrenia.

Authors:  Claudia Asenjo Lobos; Katja Komossa; Christine Rummel-Kluge; Heike Hunger; Franziska Schmid; Sandra Schwarz; Stefan Leucht
Journal:  Cochrane Database Syst Rev       Date:  2010-11-10

Review 7.  The 2009 schizophrenia PORT psychopharmacological treatment recommendations and summary statements.

Authors:  Robert W Buchanan; Julie Kreyenbuhl; Deanna L Kelly; Jason M Noel; Douglas L Boggs; Bernard A Fischer; Seth Himelhoch; Beverly Fang; Eunice Peterson; Patrick R Aquino; William Keller
Journal:  Schizophr Bull       Date:  2009-12-02       Impact factor: 9.306

8.  Add-on fluvoxamine treatment for schizophrenia: an updated meta-analysis of randomized controlled trials.

Authors:  Taro Kishi; Tomoya Hirota; Nakao Iwata
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2013-04-21       Impact factor: 5.270

Review 9.  Worldwide Differences in Regulations of Clozapine Use.

Authors:  Jimmi Nielsen; Corina Young; Petru Ifteni; Taishiro Kishimoto; Yu-Tao Xiang; Peter F J Schulte; Christoph U Correll; David Taylor
Journal:  CNS Drugs       Date:  2016-02       Impact factor: 5.749

Review 10.  Clozapine versus typical neuroleptic medication for schizophrenia.

Authors:  Adib Essali; Nahla Al-Haj Haasan; Chunbo Li; John Rathbone
Journal:  Cochrane Database Syst Rev       Date:  2009-01-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.